Fangmeng Fu

929 total citations
31 papers, 588 citations indexed

About

Fangmeng Fu is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Fangmeng Fu has authored 31 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Fangmeng Fu's work include BRCA gene mutations in cancer (6 papers), Advanced Fluorescence Microscopy Techniques (4 papers) and HER2/EGFR in Cancer Research (4 papers). Fangmeng Fu is often cited by papers focused on BRCA gene mutations in cancer (6 papers), Advanced Fluorescence Microscopy Techniques (4 papers) and HER2/EGFR in Cancer Research (4 papers). Fangmeng Fu collaborates with scholars based in China, United States and United Kingdom. Fangmeng Fu's co-authors include Morey S. Moreland, Johnny Huard, Charles S. Day, Channarong Kasemkijwattana, Michael Vogt, Jacques Ménétrey, P. Bosch, Chuan Wang, Molly T. Vogt and Yuxiang Lin and has published in prestigious journals such as PLoS ONE, Cancer and Annals of Oncology.

In The Last Decade

Fangmeng Fu

28 papers receiving 562 citations

Peers

Fangmeng Fu
Comparison fields: 5 of 68
  • Molecular Biology 239
  • Surgery 211
  • Orthopedics and Sports Medicine 108
  • Oncology 71
  • Genetics 69
Replace Anna E. Rapp with:
Anna E. Rapp Germany
Andrew Freidin United Kingdom
Nathan A. Wigner United States
J. Tambiah United States
Tomohiro Kayama Japan
P. Lencel France
Chunmiao Jiang China
Abelardo Medina Canada
Jun Qi China
Anna Burdzińska Poland
Anna E. Rapp Germany View profile →
Citations per field, relative to Fangmeng Fu
Fangmeng Fu · 1×
Citations per year, relative to Fangmeng Fu
Fangmeng Fu · 1×

Countries citing papers authored by Fangmeng Fu

Since Specialization
Citations

This map shows the geographic impact of Fangmeng Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangmeng Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangmeng Fu more than expected).

Fields of papers citing papers by Fangmeng Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangmeng Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangmeng Fu. The network helps show where Fangmeng Fu may publish in the future.

Co-authorship network of co-authors of Fangmeng Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Fangmeng Fu. A scholar is included among the top collaborators of Fangmeng Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangmeng Fu. Fangmeng Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 8
2 0
3 0
4 1
5 0
6 5
7 7
8 2
9 2
10 4
11 7
12 7
13 11
14 23
15 11
16 26
17 2
18 13
19 37
20 2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026